Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-113-5 | CAS number: 103-45-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 30 August 2002 to 19 September 2002
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Modern, guideline and GLP compliant study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 002
- Report date:
- 2002
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- Phenethyl acetate
- EC Number:
- 203-113-5
- EC Name:
- Phenethyl acetate
- Cas Number:
- 103-45-7
- Molecular formula:
- C10H12O2
- IUPAC Name:
- 2-phenylethyl acetate
Constituent 1
Method
- Target gene:
- The objective of this study was to evaluate the test substance for its ability to induce reverse mutations in a gene of histidine-requiring Salmonella typhimurium bacterial strains resulting in histidine-independent strains.
The strains TA98 and TA1537 are capable of detecting frameshift mutagens, strains TA100, TA1535 and TA102 are capable of detecting base-pair substitution mutagens
Species / strain
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and TA 102
- Metabolic activation:
- with and without
- Metabolic activation system:
- S-9 mix
- Test concentrations with justification for top dose:
- In the direct plate assay the doses (µg/plate) used with and without S-9 mix for the TA1535, TA1537, TA98, TA100 and TA102 tester strains were:
3, 10, 33, 100, 333, 1000, 3330 (and 5000 strain TA100 only)
The same doses were used inthe pre-incubation assay. - Vehicle / solvent:
- 0.1 ml dimethyl sulphoxide
Controlsopen allclose all
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 9-aminoacridine
- 2-nitrofluorene
- sodium azide
- methylmethanesulfonate
- other: daunomycin and cumene hydroperoxide
- Remarks:
- positive controls used in plate incorporation and preincubation assays without metabolic activation
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: 2-aminoanthracene (2AA) and 1,8-dihydroxanthraquinone (Danthron)
- Remarks:
- positive controls usd with metabolic activation in plate incorporation and preincubation assays
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium; in agar (plate incorporation); preincubation
plate incorporation
Top agar in top agar tubes was molten and heated to 45°C. The following solutions were successively added to 3 ml molten top agar: 0.1 ml of a fresh bacterial culture (109 cells/ml) of one of the tester strains, 0.1 ml of a dilution of the test substance in dimethyl sulfoxide and either 0.5 ml 59-mix (in case of activation assays) or 0.5 ml 0.1 M phosphate buffer (in case of non-activation assay. The ingredients were mixed on a Vortex and the content of the top agar tube was poured onto a selective agar plate. After solidification of the top agar, the plates were turned and incubated in the dark at 37°C for 48 h. After this period revertant colonies were counted.
pre-incubation
Top agar in top agar tubes was molten and heated to 45°C. The following solutions were preincubated for 30 minutes by 70 rpm at 37°C, either 0.5 ml 59-mix (in case of activation assays) or 0.5 ml 0.1 M phosphate buffer (in case of non-activation assays), 0.1 ml of a fresh bacterial culture (10'cells/ml) of one of the tester strains, 0.1 ml of a dilution of the test substance in dimethyl sulfoxide. After the preincubation period the solutions were added to 3 ml molten top agar. The ingredients were mixed on a Vortex and the content of the top agar tube was poured onto a selective agar plate. After solidification of the top agar, the plates were turned and incubated in the dark at 37°C for 48 h. After this period revertant colonies were counted.
OTHER:
The characteristics of the different Salmonella typhimurium strains were as follows:
(Strain, Histidine mutation, Plasmid, Mutation type)
TA1537, hisC3076, -, Frameshift
TA98, hisD30521R-factor, pKM101, Frameshift
TA1535, hisG46, - , Base-pair substitutions
TA100, hisG46/R-factor, pKM101, Base-pair substitutions
TA102, hisG428, pAQ1, Base-pair substitutions
Each tester strain contained the following additional mutations:
rfa : deep rough (defective lipopolysaccharide cellcoat)
gal : mutation in the galactose metabolism
chi : mutation in nitrate reductase
bio : defective biotin synthesis .
uvrB : loss of the excision repair system (deletion of the ultraviolet-repair B gene)
The Salmonella typhimurium strains were regularly checked to confirm their histidine requirement, crystal violet sensitivity, ampicillin resistance (TA98, TA100 and TA102), tetracycline resistance (TA102), UV-sensitivity and the number of spontaneous revertants. - Evaluation criteria:
- The revertant colonies were counted automatically with a Pratos model 50000 colony counter or manually, if less than 40 colonies per plate were present. Plates with sufficient test article precipitate to interfere with automated colony counting were counted manually.
The reverse mutation assay is acceptable if:
the negative control data are within laboratury background data from historical studies (these data are presented in the study report) for each tester strain
the positive controls should produce responses that are within their historical background ranges (also presented in the report) for each strain.
The selected dose range should include a clearly toxic concentration or should exhibit limited solubility or the dose range should extend to 5 mg/plate.
A test substance is considered negative (not mutagenic) in the test if:
a) The total number of revertants in any tester strain at any concentration is not greater than two times the solvent control value, with or without metabolic activation.
b) The negative response should be reproducible in at least one repeated experiment.
A test substance is considered positive (mutagenic) in the test if:
a) It induces at least a 2-fold, dose related increase in the number of revertants with respect to the number induced by the solvent control in any of the tester strains, either with or without metabolic activation.
However, any mean plate count of less than 20 is considered to be not significant.
b) The positive response should be reproducible in at least one repeated experiment. - Statistics:
- No data: not required
Results and discussion
Test results
- Species / strain:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and TA 102
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- The negative and strain-specific positive control values were within the laboratory background historical control data ranges, indicating that the test conditions were adequate and that the metabolic activation system functioned properly, except the response for TA1537 in the absence of S9-mix (second experiment; positive control). However, since this value was just outside the limit of the range and a more than three-fold increase was observed compared to the solvent control, the validity of the test was considered to be not affected.
All bacterial strains showed negative responses over the entire dose range, i.e. no dose-related. two-fold, increase in the number of revertants in two separate experiments. - Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information):
negative
Based on the results of this study it is concluded that phenyleythyl acetate is not mutagenic in the Salmonella typhimurium reverse mutation assay. - Executive summary:
Phenylethyl acetate was tested in the Salmonella typhimunum reverse mutation assay with five histidine-requiring strains of Salmonella typhimunum (TA1535, TA1537, TA98, TA100 and TA102). The test was performed in two separate experiments in the presence and absence of S9-mix (Aroclor-1254 induced rat liver S9-mix). In the direct plate assay, at first phenylethyl acetate was tested in a dose range finding study up to concentrations of 5000 µg/plate in strain TA100. Phenylethyl acetate precipitated on the plates at dose levels of 3330 and 5000 µg/plate. Toxicity was observed at dose levels of 3330 and 5000 µg/plate. Phenylethyl acetate was tested up to concentrations of 3330 µg/plate in the strains TA1535, TA1537, TA98 and TA102. Phenylethyl acetate precipitated on the plates at this dose level. No biologically relevant decrease in the number of revertants was observed.
In the preincubation assay phenylethyl acetate was tested in a dose range finding study in the strain TA100. Phenylethyl acetate was tested up to concentrations of 5000 µg/plate. Toxicity was observed at dose levels of 1000 µg/plate and upwards. After that, phenylethyl acetate was tested up to concentrations of 3330 µg/plate in the strains TA1535, TA1537, TA98 and TA102. Toxicity was observed in all tester strains. Phenylethyl acetate did not induce a dose-related increase in the number of revertant (His+) colonies in each of the five tester strains (TA1535, TA1537, TA98, TA100 and TA102) both in the absence and presence of S9-metabolic activation. These results were confirmed in independently repeated experiments. Based on the results of this study it is concluded that phenylethyl acetate is not mutagenic in the Salmonella typhimurium reverse mutation assay.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.